TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Folic acid deficiency by age group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vitamin B12 deficiency by religious origin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Degree of inflammation after short term treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial degree of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of expression levels of inflammatory cytokine mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of expression levels of inflammatory cytokine protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Combined number of units of allogeneic blood products administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of True Positives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of True Negatives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of antipsychotic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width of fetal interventricular heart septum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bowel transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean Pain Scores at Endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes of FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Vasodilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Death/MACE
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Adverse Events Including Serious Adverse Events (SAEs) and Adverse Events of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Laboratory Assessment Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinically Significant Vital Signs Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular Surface Disease Index (OSDI) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physician global assessment multiplied by body surface area improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Adjusted Change From Baseline in Glycated Haemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Yale Global Tic Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of stuttering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ad Libitum Energy Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Partial Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of germline driver mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Identification of somatic driver mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: HCV infection outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Women Prepared for Pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Complete molecular response (CMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Overall response (OR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: number of patients enhancing social interaction
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Immunogenicity of the MUC1 Vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Count of Patients Experiencing 1 or More Grade 3+ Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: maximum observed serum or plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the serum or plasma concentration-time curve from 0 to t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the serum or plasma concentration-time curve from 0 to infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: pharmacokinetics of digoxin and midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Speech Perception in Noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-HBs antibody concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Heat pain response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: end organ function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Death or Bronchopulmonary Dysplasia (BPD) at 36 weeks PMA
Endpoint domain: Mortality/survival
Primary endpoint: Time to initiation of first-line systemic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in gradient-echo T2*-weighted signal in the globus pallidus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Subjects Reporting Solicited Local Symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Reporting Solicited General Symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence of Atrial Fibrillation (AF) > 30 Seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Spiritual Well-Being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Achieving recommended sleep levels
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of participants who received MCV by 12 months of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole-Mouth Mean Modified Gingival Index (MGI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole Mouth Mean Turesky Plaque Index (TPI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of occurrence of early POCD
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of occurrence of intermediate POCD
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of occurrence of late POCD
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of patients with improvement in severity of spasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of vaccine-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of bleeding events as defined by BARC criteria
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who undergo colorectal screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: PDQ-8
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Flow-mediated dilation of the branchial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Measurement of cystatin C in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Global symptom index (GSI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bacterial infection detection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Yeast infection detection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Chlamydia trachomatis detection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Neisseria gonorrhoeae detection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Mycoplasma genitalium detection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Trichomonas vaginalis detection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Human simplex virus detection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in auditory hallucination rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulties in Emotional Regulation (DERS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Becks Depression Inventory (BDI-II)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Becks Anxiety Inventory (BAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Liver Function Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Markedly Abnormal Change in Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Markedly Abnormal Change in Body Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TG Plasma AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: B48 Plasma AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TG Plasma iAUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Positive diagnosis of an APA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disturbingness of low back related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aerial Bone Mineral Density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic value of next-generation sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Distal femoral Bone mineral density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Drug levels on Day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Best-corrected Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change From Baseline in Schiff Sensitivity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of women with MBL2 gene mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of B-cells in peripheral blood mononuclear cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of cases of Dose-limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in Worst-itching Visual Analog Scale (VAS) at week 4
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in 5-D Itch Scale score at week 4
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in Dermatology life quality index (DLQI) at week 4
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of symptomatic and inapparent dengue infection
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of Aedes aegypti salivary gland homogenate reactivity
Endpoint domain: Adverse events/effects
Primary endpoint: Growth of dermal neurofibromas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: sample weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of hepatic fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Eye pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of infecting agent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Diagnosis of underlying susceptibility trait
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline in Total Score on the Scale for the Assessment and Rating of Ataxia (SARA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Intravascular enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median modified Neoadjuvant Rectal (mNAR) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TMA Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minimum cross-sectional area of the upper airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Adequate Estrogen Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of subjects with Adverse Drug Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: prevalence of COVID-19 exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Safety of OAC therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of OAC therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with complications or death
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients developing Catheter related thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of major hypoglycaemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Actigraphy-derived sleep efficiency (SE)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Actigraphy-derived respiratory sinus arrhythmia (RSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Nightmare Frequency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Composite of non-fatal myocardial infarction, death, or stent thrombosis
Endpoint domain: Mortality/survival
Primary endpoint: Body constitution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICI-Q-SF score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hematopoietic non-engraftment
Endpoint domain: Adverse events/effects
Primary endpoint: Systolic blood pressure (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diastolic blood pressure (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pulse (beat/minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in FACT-COG result
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Subjects With Serum Bactericidal Assay Antibody Titers ≥ Cut-off Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunology Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Drug Related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With AEs Leading to Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Deaths
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of allogeneic blood products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of patients who do not receive any RBC transfusions or any allogeneic blood transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hereditary factor evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sufficient interest in participation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Preliminary improvement in well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in Physical functioning of knee joints
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in femoral cartilage thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Late Driving Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean shoulder pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with arm volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: MRI signal across the whole brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Change in the Postoperative End Tidal CO2/O2 Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: D-dimer Concentration Relative to the Preoperative Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Probability of Pulmonary Embolism Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication regimen knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Matched VE Participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve from 0 to infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve from 0 to last quantifiable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular health status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Standardization of bleeding management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to reach MM-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of drug remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention Uptake (acceptability)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Coverage (feasibility)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Liver fat deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Internalised Shame Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Stigma Scale- Short
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: World Health Organisation- Five Well-Being Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CompACT Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Client Satisfaction Questionnaire-8 (CSQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Proportion of Participants With Hepatic Encephalopathy (HE) Breakthrough Episode
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Incisional Hernia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Plasma concentration of sotaglifozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Condomless Sex Acts
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of Boys Reporting Abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction of flank circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of PrEP Implementation Activities Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to Completion for Each Implementation Phase
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost and Resource Allocation for Completion of Each Implementation Phase
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of dose-limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of STI testing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Quality-Adjusted Survival Times
Endpoint domain: Mortality/survival
Primary endpoint: Count of safety events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of serious adverse events (SAE) and adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of somatic mutations or methylation profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Screening-eligible Visits at Which Depression Screening is Completed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention